Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefits: PQQ: Human health impacts and benefits
- PMID: 39513102
- PMCID: PMC11541945
- DOI: 10.1016/j.crfs.2024.100889
Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefits: PQQ: Human health impacts and benefits
Abstract
Pyrroloquinoline Quinone (PQQ) is a redox-active quinone molecule with significant implications for human health. Originally identified as a bacterial cofactor, PQQ has since been lauded for its diverse biological and therapeutic activities. It serves as an essential cofactor for oxidative enzymes that are vital for mitochondrial function and ATP synthesis. PQQ exhibits superior antioxidant properties that protect against ROS-mediated oxidative stress, aging, neurodegenerative diseases, certain cancers, diabetes, and metabolic disorders. It also enhances cognitive abilities and reduces insulin sensitivity. PQQ's antioxidant nature helps mitigate oxidative stress, which is implicated in many diseases. It has been shown to target cancer cells selectively, suggesting its potential as a therapeutic agent. Clinical studies have indicated the potential benefits of PQQ supplementation, including improvements in cardiovascular health, cognitive function, weight management, insulin sensitivity, and the prevention of metabolic syndromes. The safety of PQQ has been established, with no reported toxicity or genotoxicity in various studies, and it is considered a safe nutritional supplement. Future research directions should focus on determining the optimal dosages of PQQ for specific health outcomes and assessing its long-term effectiveness and safety. The translation of PQQ research into clinical practice could offer new strategies for managing metabolic disorders, enhancing cognitive health, and potentially extending lifespan. In summary, PQQ is a promising molecule with broad potential health benefits, impacting human health from cellular metabolism to disease prevention and treatment, positioning it as a key player in nutritional science and public health.
Keywords: Antioxidant; Cardiovascular health; Cellular metabolism; Metabolic disorders; Neuroprotection; Pyrroloquinoline quinone.
© 2024 The Authors. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that there are no financial or other relationships that might lead to a conflict of interest of the present article. All authors have reviewed the final version of the manuscript and approved it for publication.
Figures





Similar articles
-
Current study on Pyrroloquinoline quinone (PQQ) therapeutic role in neurodegenerative diseases.Mol Biol Rep. 2025 Apr 15;52(1):397. doi: 10.1007/s11033-025-10491-6. Mol Biol Rep. 2025. PMID: 40234255 Review.
-
Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention.Biomolecules. 2021 Sep 30;11(10):1441. doi: 10.3390/biom11101441. Biomolecules. 2021. PMID: 34680074 Free PMC article. Review.
-
Pyrroloquinoline quinone alleviates natural aging-related osteoporosis via a novel MCM3-Keap1-Nrf2 axis-mediated stress response and Fbn1 upregulation.Aging Cell. 2023 Sep;22(9):e13912. doi: 10.1111/acel.13912. Epub 2023 Jun 26. Aging Cell. 2023. PMID: 37365714 Free PMC article.
-
Pyrroloquinoline quinone enhances the resistance to oxidative stress and extends lifespan upon DAF-16 and SKN-1 activities in C. elegans.Exp Gerontol. 2016 Jul;80:43-50. doi: 10.1016/j.exger.2016.04.008. Epub 2016 Apr 14. Exp Gerontol. 2016. PMID: 27090484
-
Recent progress in studies on the health benefits of pyrroloquinoline quinone.Biosci Biotechnol Biochem. 2016;80(1):13-22. doi: 10.1080/09168451.2015.1062715. Epub 2015 Jul 13. Biosci Biotechnol Biochem. 2016. PMID: 26168402 Review.
Cited by
-
Pyrroloquinoline Quinone (PQQ) Attenuates Hydrogen Peroxide-Induced Injury Through the Enhancement of Mitochondrial Function in Human Trabecular Meshwork Cells.Int J Mol Sci. 2025 Jul 19;26(14):6938. doi: 10.3390/ijms26146938. Int J Mol Sci. 2025. PMID: 40725185 Free PMC article.
-
Assessment of the Capability of Mesenchymal Stem Cells and/or Pyrroloquinoline Quinone in Compensating the Age-Related Dysfunctions of AMP-Activated Protein Kinase Pathway in Wistar Rats.Cell Biochem Biophys. 2025 Mar 6. doi: 10.1007/s12013-025-01693-7. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40048044
-
Pre-conditioning with PQQ during pregnancy alleviates LPS-induced placental damage and improves the fetal survival and growth in mice.Front Endocrinol (Lausanne). 2025 Jul 10;16:1617026. doi: 10.3389/fendo.2025.1617026. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40708725 Free PMC article.
-
Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Disease: Spike Persistence as the Core Culprit and Its Downstream Effects.Diseases. 2025 Jun 30;13(7):204. doi: 10.3390/diseases13070204. Diseases. 2025. PMID: 40709992 Free PMC article.
-
Current study on Pyrroloquinoline quinone (PQQ) therapeutic role in neurodegenerative diseases.Mol Biol Rep. 2025 Apr 15;52(1):397. doi: 10.1007/s11033-025-10491-6. Mol Biol Rep. 2025. PMID: 40234255 Review.
References
-
- Ameyama M., Shinagawa E., Matsushita K., Adachi O. Growth stimulating substance for microorganisms produced by Escherichia coli causing the reduction of the lag phase in microbial growth and identity of the substance with pyrroloquinoline quinone. Agric. Biol. Chem. 1984;48(12):3099–3107. doi: 10.1080/00021369.1984.10866645. - DOI
Publication types
LinkOut - more resources
Full Text Sources